Dried blood spot analysis without dilution: Application to the LC-MS/MS determination of BMS-986001 in rat dried blood spot

被引:4
作者
Yuan, Long [1 ]
Schuster, Alan [1 ]
Shen, Jim X. [1 ]
Garrison-Borowski, Pamela [2 ]
Aubry, Anne-Francoise [1 ]
机构
[1] Bristol Myers Squibb Co, Analyt & Bioanalyt Dev, Princeton, NJ 08543 USA
[2] Bristol Myers Squibb Co, Drug Safety Evaluat, New Brunswick, NJ 08903 USA
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2015年 / 1002卷
关键词
Dried blood spot; Dilution; Extended linear range; Quantitation; LC-MS/MS; Regulated bioanalysis; TANDEM MASS-SPECTROMETRY; QUANTITATIVE BIOANALYSIS; SAMPLE PREPARATION; DIRECT ELUTION; UHPLC-MS/MS; STANDARD; ASSAYS; HEMATOCRIT; EXTRACTION; DRUGS;
D O I
10.1016/j.jchromb.2015.08.029
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Sample dilution is one major challenge in dried blood spot (DBS) bioanalysis. To resolve this issue, we applied a no-dilution strategy for DBS analysis by using a calibration curve with very wide linear range. We developed an LC-MS/MS DBS assay with a linear range of 5 orders of magnitude (50-5000,000 ng/mL) for BMS-986001, an HIV drug under development, by simultaneously monitoring two selective reaction monitoring transitions of different intensity. The assay was validated and successfully applied to the analysis of DBS samples collected in a toxicology study in rats dosed with BMS-986001. All samples were analyzed without any dilution. We also compared the concentration data generated from the DBS method and a validated plasma assay for the same study. The two sets of data agreed well with each other, demonstrating the validity of this strategy for DBS analysis. This approach provides an effective and convenient way to eliminate complicated dilution for DBS and other sample collection techniques. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:201 / 209
页数:9
相关论文
共 31 条
[1]  
Abu-Rabie P, 2011, BIOANALYSIS, V3, P2769, DOI [10.4155/BIO.11.270, 10.4155/bio.11.270]
[2]  
Broom H., 2009, Animal Technology and Welfare, V8, P21
[3]   Utilization of dried blood spots within drug discovery: modification of a standard DiLab® AccuSampler® to facilitate automatic dried blood spot sampling [J].
Clark, G. T. ;
Giddens, G. ;
Burrows, L. ;
Strand, C. .
LABORATORY ANIMALS, 2011, 45 (02) :124-126
[4]   DBS sampling can be used to stabilize prodrugs in drug discovery rodent studies without the addition of esterase inhibitors [J].
D'Arienzo, Celia J. ;
Ji, Qin C. ;
Discenza, Lorell ;
Cornelius, Georgia ;
Hynes, John, Jr. ;
Cornelius, Lyndon ;
Santella, Joseph B. ;
Olah, Timothy .
BIOANALYSIS, 2010, 2 (08) :1415-1422
[5]   Dried Blood Spot Bioanalysis: An Evaluation of Techniques and Opportunities for Reduction and Refinement in Mouse and Juvenile Rat Toxicokinetic Studies [J].
Dainty, Tim C. ;
Richmond, Emily S. ;
Davies, Ian ;
Blackwell, Malcolm P. .
INTERNATIONAL JOURNAL OF TOXICOLOGY, 2012, 31 (01) :4-13
[6]  
Davies SJ, 2014, BIOANALYSIS, V6, P843, DOI [10.4155/bio.14.26, 10.4155/bio.13.320]
[7]   The effect of hematocrit on bioanalysis of DBS: results from the EBF DBS-microsampling consortium [J].
de Vries, Ronald ;
Barfield, Matthew ;
van de Merbel, Nico ;
Schmid, Bernhard ;
Siethoff, Christoph ;
Ortiz, Jordi ;
Verheij, Elwin ;
van Baar, Ben ;
Cobb, Zoe ;
White, Steve ;
Timmerman, Philip .
BIOANALYSIS, 2013, 5 (17) :2147-2160
[8]   Dried Blood Spots: Analysis and Applications [J].
Demirev, Plamen A. .
ANALYTICAL CHEMISTRY, 2013, 85 (02) :779-789
[9]   The effect of hematocrit on assay bias when using DBS samples for the quantitative bioanalysis of drugs [J].
Denniff, Philip ;
Spooner, Neil .
BIOANALYSIS, 2010, 2 (08) :1385-1395
[10]  
European Medicines Agency, 2022, Committee for Medicinal Products for Human Use, Guideline on Bioanalytical Method Validation